TRCT
CRCD

Tower Research Capital (TRC)’s T-REX 2X Inverse CRCL Daily Target ETF CRCD Stock Holding History

Tower Research Capital (TRC)’s Portfolio CRCD Stock Details CRCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$419 Sell
60
-40
-40% -$188 ﹤0.01% 5040
2026
Q1 		$675 Sell
100
-14
-12% -$384 ﹤0.01% 4800
2025
Q4 		$3.92K Buy
+114
New +$3.46K ﹤0.01% 4294

Other funds holding CRCD

Optiver Holding
Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $419B AUM 72.04% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Tower Research Capital (TRC)'s CRCD Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its T-REX 2X Inverse CRCL Daily Target ETF (CRCD) stake by 40% in Q2 2026, selling an estimated $188 and leaving 60 shares worth $419. The position accounts for ﹤0.01% of the portfolio, ranked #5040.

Tower Research Capital (TRC) first reported a position in CRCD in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.92K in Q4 2025. 12 funds tracked by Wall St. Rank hold CRCD as of Q2 2026.

  • Tower Research Capital (TRC) held 60 shares of T-REX 2X Inverse CRCL Daily Target ETF worth $419 as of Q2 2026.
  • Tower Research Capital (TRC) sold 40 T-REX 2X Inverse CRCL Daily Target ETF shares in Q2 2026, an estimated $188.
  • T-REX 2X Inverse CRCL Daily Target ETF made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #5040 holding.
  • Tower Research Capital (TRC) first reported a position in T-REX 2X Inverse CRCL Daily Target ETF in Q4 2025 and has held it in 3 quarters since.
  • Tower Research Capital (TRC)'s T-REX 2X Inverse CRCL Daily Target ETF position peaked at $3.92K in Q4 2025.
  • 12 funds tracked by Wall St. Rank held T-REX 2X Inverse CRCL Daily Target ETF as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.